ARQT — Arcutis Biotherapeutics, Inc. stock price, charts and financials

QT67Arcutis Biotherapeutics, Inc.

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
25.70
+0.41+1.62%
ARQTQT67Arcutis Biotherapeutics, Inc.·NASDAQ
25.70+1.62%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 20268-KCurrent report
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 20264Statement of changes in beneficial ownership
Aug 05, 202610-QQuarterly report
Jul 17, 20263Initial statement of beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 16, 20268-KCurrent report
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 12, 20264/AStatement of changes in beneficial ownership (amended)
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20264Statement of changes in beneficial ownership
Jun 09, 20268-KCurrent report
Jun 09, 20264Statement of changes in beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 12, 2026SC 13GBeneficial ownership statement (passive)